Good morning, everyone, and how are you today? We are doing just fine, thank you, courtesy of an unseasonable spot of cool weather for this time of year. Cool breezes are wafting across the Pharmalot campus, which is also benefiting from a warm and shiny sun. Throw in a cup of stimulation and you have a delightful start to the day. On that note, please enjoy the items we have assembled for you. Meanwhile, we should note that we will take a long holiday break, so a colleague will pick up the pace tomorrow. We will, however, return Tuesday. Hope those of you on this side of the pond have a lovely respite yourselves. Enjoy, and see you soon. …

The National Academies of Science, Engineering, and Medicine has not disclosed that one of its presidents and members of a panel that was convened to advise on prescribing opioids had recent links to the pharmaceutical industry, BMJ reports. For instance, the quasi-independent organization claimed 15 academics appointed to the panel and who serve pro bono for the 16-month project, are free of conflicts of interest. But seven panelists disclosed ties to the drug or health care industry in recent scholarly work on pain.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy